Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
$1.50
$1.50
$0.64
$15.52
$13.16M3.1815,714 shsN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
$9.26
$7.40
$6.65
$10.71
N/AN/A2,529 shs3,242 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.15
$1.41
$0.25
$3.40
$8.55M5.8532,617 shs30,632 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
0.00%0.00%0.00%0.00%+10.65%
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
0.00%+12.93%+36.18%+38.11%-7.58%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-4.07%-13.87%-17.48%+267.60%+50.18%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
N/AN/AN/AN/AN/AN/AN/AN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/AN/AN/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
N/AN/AN/AN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
$1.88M7.00N/AN/A$0.18 per share8.33
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$158.86K53.84N/AN/A$0.31 per share3.71

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
-$8.64MN/A0.00N/AN/AN/AN/AN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/A0.00N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65MN/A0.00N/A-3,106.71%-154.87%-122.97%8/9/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
N/AN/AN/AN/AN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
N/AN/AN/A
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
5.06
4.75

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
0.04%
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%

Insider Ownership

CompanyInsider Ownership
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
16.00%
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
27.69%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced Health Intelligence Ltd stock logo
AHI
Advanced Health Intelligence
N/A8.77 million7.37 millionNot Optionable
accesso Technology Group plc stock logo
LOQPF
accesso Technology Group
672N/AN/ANot Optionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
67.44 million5.38 millionNot Optionable

NXL, 9SP, LOQPF, and AHI Headlines

Recent News About These Companies

Nexalin Technology (NASDAQ:NXL) Stock Price Down 1.5%
Nexalin Technology CEO Provides Letter to Shareholders

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Advanced Health Intelligence logo

Advanced Health Intelligence

NASDAQ:AHI
Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.
accesso Technology Group logo

accesso Technology Group

OTCMKTS:LOQPF
accesso Technology Group plc, together with its subsidiaries, develops technology solutions for the attractions and leisure industry in the United Kingdom, other European countries, Australia, the South Pacific, Asia, Africa, the United States, Canada, Mexico, and Central and South America. It operates through Ticketing and Distribution, and Guest Experience segments. The company offers ticketing solutions for theme parks, ski resorts, zoos and aquariums, cultural venues, live entertainment, water parks, fairs and festivals, performing arts, and tours and attractions. It also offers various solutions, such as accesso LoQueue, a virtual queuing solution; accesso Passport ticketing suite, which provides daily tickets, season pass, group tickets, meal vouchers, and other services; and accesso Siriusware software solutions providing modules in ticketing and admissions, memberships, reservations, resource scheduling, retail, food service, gift cards, kiosks, and ecommerce services. In addition, the company provides accesso ShoWare, a ticketing solutions for box office, online, kiosk, mobile, call center, and social media sales; Ingresso operate, a consolidated distribution platform, which connects venues and distributors to sell their event, theatre and attraction tickets; accesso Paradox cutting edge software solution; accesso Horizon ticketing and visitor management solution; mobile applications experience management platforms; and accesso Freedom point of sale system. The company was formerly known as Lo-Q plc and changed its name to accesso Technology Group plc in November 2013. accesso Technology Group plc was incorporated in 2000 and is based in Twyford, the United Kingdom.
Nexalin Technology logo

Nexalin Technology

NASDAQ:NXL
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.